No further treatment

OTHER3 trials

Sponsors

University College, London, Grupo Español de Investigación en Cáncer de Ovario

Conditions

Advanced CancerCervical CancerLymphomaPlasmacytoma

Phase 2

TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation

Active, not recruitingNCT03833479

Grupo Español de Investigación en Cáncer de OvarioAdvanced Cancer, Cervical Cancer

Start: 2019-06-28End: 2028-07-31Updated: 2026-06-17

Phase 3

PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma

Active, not recruitingNCT00943423

University College, LondonLymphoma

Start: 2003-07-31End: 2028-12-31Updated: 2023-11-30

Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma

Active, not recruitingNCT02544308

University College, LondonPlasmacytoma

Start: 2017-03-10End: 2026-12-31Updated: 2022-12-23

Related Papers

Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study

Blood Advances2025-01-073 citations

Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial.

2024-10-033 citations

Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer

Clinical Cancer Research2024-01-028 citations

ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation.

2022-09-0619 citations

Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.

2022-07-1910 citations

Enhanced Outcome Prediction in Early Stage Classical Hodgkin Lymphoma Using Pre-Treatment Biomarkers and Interim PET (BioPET); A Sub-Analysis of the UK NCRI RAPID Trial

Blood2020-11-042 citations

Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

New England Journal of Medicine2015-04-22734 citations